Effects of Shuanghuanglian oral liquids on patients with COVID-19: a randomized, open-label, parallel-controlled, multicenter clinical trial

{{article.zuoZheEn}}

PDF(409 KB)
PDF(409 KB)
Front. Med. ›› 2021, Vol. 15 ›› Issue (5) : 704-717. DOI: 10.1007/s11684-021-0853-6
RESEARCH ARTICLE

Effects of Shuanghuanglian oral liquids on patients with COVID-19: a randomized, open-label, parallel-controlled, multicenter clinical trial

  • {{article.zuoZheEn}}
Author information +
History +

Highlights

{{article.highlightEn}}

Abstract

{{article.abstractEn}}

Author summary

{{article.authorSummayEn}}

Keywords

Cite this article

EndNote

Ris (Procite)

Bibtex

Download citation ▾
{{article.zuoZheEn_L}}. {{article.titleEn}}. Front. Med., 2021, 15(5): 704‒717 https://doi.org/10.1007/s11684-021-0853-6

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

RIGHTS & PERMISSIONS

{{article.copyright.year}} {{article.copyright.holder}}
AI Summary AI Mindmap
PDF(409 KB)

Accesses

Citations

Detail
Sections
Recommended

/

〈 〉